Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-06-17-Speech-2-170"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2008-06-17"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20080617.35.2-170"2
lpv:hasSubsequent	lp_eu:2008-06-17-Speech-2-1712
lpv:speaker	lp:Miroslav Mikolášik2
lpv:spokenAs	substitute; Delegation for relations with Israel (2007-03-14--2009-07-13)3 substitute; Delegation for relations with Canada (2007-03-15--2009-07-13)3 substitute; ENVI (2007-01-31--2009-07-13)3 member; Delegation to the Euro-Mediterranean Parliamentary Assembly (2004-09-15--2009-07-13)3 unknown; Kresťanskodemokratické hnutie (2004-07-20--2009-07-13)3 member; REGI (2007-01-31--2009-07-13)3 member; EPP-ED (2004-07-20--2009-07-13)3
lpv:translated text	"A high level of protection of human health and consumer safety are the fundamental interests when it comes to establishing residue limits of pharmacologically active substances in foodstuffs of animal origin. In production-bred animals, veterinary medicines can leave behind residues, which has already started to have a negative impact on both human and animal health. I welcome the report by my colleague, Mrs Doyle, and I voted in favour of it today. A more consistent approach to controlling the residues of all pharmacologically active substances, and analyses of the risk they represent, are crucial. I believe that we need to change, amend and unify the legal framework for setting maximum residue limits. I share the rapporteur’s view that by doing so we can ensure that veterinary medicines are used correctly and are more accessible, see to it that the trade in foodstuffs of animal origin functions properly and, above all, achieve optimum protection of public health."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph